This is the authors' abstract. We don't add key points for this paper.
cells similarly reduced bacterial titers in multiple organs and enhanced survival. Our results demonstrate that inhibiting USP18 function can promote control of primary and secondary bacterial infection by enhancing the antibacterial effect of TNF-α, which correlates with induction of reactive oxygen species (ROS). These findings suggest that USP18 could be targeted therapeutically in patients to ameliorate disease caused by serious bacterial infections.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shaabani et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: